Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Mark ChristiansonBusiness Development Director | Neuroone Medical TechnologiesNMTC | Open-market sale | 03/30 | 04/01 | 15,363 sh | $0.74 | $11,368.62 | −7.2% |
Neuroone Medical TechnologiesNMTC | Open-market sale | 03/12–03/13 | 03/16 | 917 sh2 trades | $0.80avg. | $733.6 | −0.4% | |
Neuroone Medical TechnologiesNMTC | Open-market sale | 03/10–03/11 | 03/12 | 13,720 sh2 trades | $0.80avg. | $10,976 | −6.0% | |
David J. WambekeChief Business Officer | Neuroone Medical TechnologiesNMTC | Open-market buy | 03/01 | 03/03 | 1,000,000 sh | $0.67 | $670,000 | No record |
Mark ChristiansonBusiness Development Director | Neuroone Medical TechnologiesNMTC | Open-market sale | 25/09/05 | 25/09/09 | 30,000 sh | $0.74 | $22,200 | −11.5% |
Mark ChristiansonBusiness Development Director | Neuroone Medical TechnologiesNMTC | Open-market sale | 25/06/04 | 25/06/05 | 10,000 sh | $0.58 | $5,800 | −3.7% |
Neuroone Medical TechnologiesNMTC | Open-market sale | 25/05/21–25/05/22 | 25/05/23 | 8,981 sh2 trades | $0.62avg. | $5,568.64 | −3.2% | |
Neuroone Medical TechnologiesNMTC | Open-market sale | 25/05/19–25/05/20 | 25/05/21 | 11,019 sh2 trades | $0.67avg. | $7,352.6 | −3.8% | |
David A. RosaCEO and President | Neuroone Medical TechnologiesNMTC | Open-market buy | 25/04/04 | 25/04/07 | 100,000 sh | $0.50 | $50,000 | +9.4% |
Neuroone Medical TechnologiesNMTC | Open-market buy | 25/04/04 | 25/04/07 | 200,000 sh | $0.50 | $100,000 | +81.9% | |
Mark ChristiansonBusiness Development Director | Neuroone Medical TechnologiesNMTC | Open-market sale | 24/06/06 | 24/06/11 | 2,189 sh | $0.88 | $1,926.32 | −0.7% |
Mark ChristiansonBusiness Development Director | Neuroone Medical TechnologiesNMTC | Open-market sale | 24/06/05 | 24/06/07 | 25,800 sh | $0.88 | $22,704 | −8.0% |
Neuroone Medical TechnologiesNMTC | Open-market sale | 23/12/26–23/12/27 | 23/12/27 | 38,293 sh2 trades | $1.44avg. | $55,154.5 | −11.3% | |
Neuroone Medical TechnologiesNMTC | Open-market sale | 23/12/21–23/12/22 | 23/12/26 | 11,707 sh2 trades | $1.40avg. | $16,389.8 | −3.3% | |
Neuroone Medical TechnologiesNMTC | Open-market buy | 23/12/21 | 23/12/26 | 75,000 sh | $1.40 | $105,000 | No record | |
Neuroone Medical TechnologiesNMTC | Open-market buy | 23/09/13 | 23/09/14 | 50,900 sh | $0.98 | $49,882 | +64.0% | |
Neuroone Medical TechnologiesNMTC | Open-market sale | 23/03/21–23/03/23 | 23/03/24 | 26,500 sh3 trades | $1.51avg. | $40,078.87 | −7.3% |